REaCT Integrated Consent Model to Compare Two Standard of Care Regimens
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The Integrated Consent Model is being increasingly used internationally to improve patient
care. In this feasibility study we will explore whether the model is feasible in practice;
and whether it can be used to increase the number of physicians and patients who take part in
clinical trials, and address the critical issue around the optimal febrile neutropenia
prevention by randomizing eligible patients to either G-CSF or ciprofloxacin.